Cost Impact of Switching Histamine2-Receptor Antagonists to Nonprescription Status
| Publication | Article in Annals of Pharmacotherapy, published July 2002 |
|---|---|
| Authors | Michelle D Furler, Mark S Rolnick, Kathleen S Lawday, Miranda W Mak, Thomas R Einarson |
This is the public page for a publication record in Dimensions, a free research insights platform that brings together information about funding, scholarly outputs, policy, patents and grants.
Loading metrics…